Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ICICI Prudential Nifty Pharma ETF · Regular ✕Mirae Asset Nifty 200 Alpha 30 ETF · Regular ✕

Growth of ₹10,000

Basics

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
CategoryEquity ETFsEquity ETFs
PlanRegularRegular
Fund houseICICI PruMirae Asset
NAV₹28.3748₹26.4463
NAV date20 Nov 202619 Nov 2026
History1 months3.1 years
Expense ratio5.7%0.7%
StarsNot ratedNot rated
Growth Score——

Returns

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
1 month+10.14%+6.05%
3 months—+0.04%
6 months—+3.88%
YTD—+5.92%
1 year—+2.56%
3 years (CAGR)—+13.00%
5 years (CAGR)——
10 years (CAGR)——
Since launch+10.14%+16.18%

Risk

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
Volatility—21.4%
Downside volatility—15.4%
Sharpe—0.30
Sortino—0.42
Calmar—0.43
Return / risk—0.61
Deepest fall−2.74%−30.00%
Days to recover——
Below its high−1.75%−10.37%

Against benchmark

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
Best 1-year—+63.16%
Middle 1-year—+1.17%
Worst 1-year—−16.84%
1-year periods with a loss—45.3%
Middle 3-year—+13.81%
Positive months—63.9%
Best day—+5.40%
Worst day—−11.95%
Worst 5% day—−2.22%
Positive days—56.5%
NAVs a year—248

SIP of ₹10,000 a month

ICICI Prudential Nifty Pharma ETFMirae Asset Nifty 200 Alpha 30 ETF
5-year XIRR——
5-year value——
3-year XIRR—+5.24%
1-year XIRR—+8.70%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth